Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1978-04-03
1980-04-15
Rosen, Sam
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
424273P, A61K 3162
Patent
active
041984021
ABSTRACT:
Ulcer production in animals is prevented during prolonged antiphlogistic treatment with ulcerogenic quantities of phenylbutazone by using it in a composition of 1 part of antiphlogistic to 0.2 to 50 parts by weight of alkali metal salicylate.
REFERENCES:
Gietka et al.-Chem. Abst., vol. 82, (1975), p. 291p.
Trinus et al.-Chem. Abst., vol. 77, (1972), p. 135,081n.
Kirichek-Chem. Abst. vol., 76, (1972), p. 121,798u.
Mhirden et al.-Chem. Abst., vol. 82, (1975), p. 38,749g.
Zathurecky et al.-Chem. Abst., vol. 82, (1975), p. 164,817r.
Cholnoky Eszter
Ezer Elemer
Forgach Lilla
Gidai Katalin
Hajos Gyorgy
Richter Gedeon Vegyeszeti Gyar Rt.
Rosen Sam
Ross Karl F.
LandOfFree
Antiphlogistic composition of phenylbutozone and alkali salicyla does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiphlogistic composition of phenylbutozone and alkali salicyla, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiphlogistic composition of phenylbutozone and alkali salicyla will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-475985